Shaping Convergent Strategies in Comparative Effectiveness Research
Thursday, June 24, 2010
The momentum behind expanding the nation’s capacity to generate comparative effectiveness research (CER ) is reaching a crucial stage. Most stakeholders believe that better evidence about quality and value will drive better clinical decision-making, thus improving patient health outcomes. But the success of any national CER initiatives will depend on how evidence is developed, whether it is credible, and how it is used by patients, providers, and payers.
To date, much of the conversation regarding CER has been focused on the best ways to fund and generate new research findings. In contrast, relatively little attention has addressed CER methods and the dissemination and interpretation of the research findings. "Shaping Convergent Strategies for Comparative Effectiveness Research" examined how CER information will be developed, managed, disseminated, and adopted within the unique multi-stakeholder community of the U.S. health care arena. This diversity is represented by the multiple sponsors of the conference, as well as the wide array of thought-leader panelists. Speakers from academia and the policy community, as well as those representing government, consumers, employers, pharmaceuticals, insurers, and delivery systems addressed the questions about how CER will be employed in a way that informs decisions, improves health, and enhances the overall performance of our health care system.
To view speaker presentations, click on the speaker name below. (Note: not all speakers utilized PowerPoint presentations.)
Keynote
A historical snapshot and vision of comparative effectiveness research for the next decade. |
| |
|
| |
|
Gail R. Wilenksy, PhD, Senior Fellow, Project HOPE/Health Affairs
|
The Patient-Centered Outcomes Research Institute (PCORI)
The establishment of the Patient-Centered Outcomes Research Institute (PCORI) to conduct research and disseminate finding with respect to "the relative health outcomes, clinical effectiveness and appropriateness" of medical treatments ensures that comparative effectiveness research (CER) will play an important role in providing evidence-based analysis for physicians and consumers. Speakers will discuss legislative intent in establishing PCORI, the operational definition of comparative effectiveness research, next steps for implementation, and the likely impact on health care decision-making.
|
| |
|
| |
 |
Carolyn M. Clancy, MD, Director, Agency for Healthcare Research and Quality (AHRQ) |
| |
 |
Michael S. Lauer, MD, FACC, FAHA, Director, Division of Cardiovascular Sciences (DCVS), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health
|
| |
|
Sarah Kuehl, Senior Budget Analyst, Democratic Staff, U.S. Senate Budget Committee
|
| |
|
|
Defining Good Evidence to Inform Decision-Making and High-Value Health Care Services
How can we ensure a more predictable and transparent environment where credible evidence is generated and interpreted with high scientific standards in order to inform health care decision-making? How do we ensure that CER findings are disseminated in a timely fashion with adequate reference to the findings strengths, weaknesses and other limitations as well as provide information that is understandable by consumers?
|
|
|
 |
Sean Tunis, MD, MSc, Founder and Director, Center for Medical Technology Policy |
| |
 |
Barbara J. McNeil, MD, PhD, Head, Department of Health Care Policy and Ridley Watts Professor of Health Care Policy, Harvard Medical School; Practicing Radiologist, Brigham and Women's Hospital
|
| |
 |
Nancy A. Dreyer, MPH, PhD, FISPE, Chief of Scientific Affairs and Senior Vice President, Outcome Sciences, Inc.
|
| |
 |
Kathleen A. Buto, Vice President, Health Policy, Johnson & Johnson
|
| |
 |
Moderator: Les Paul, MD, MS, Vice President, Clinical and Scientific Affairs, National Pharmaceutical Council
|
|
|
|
Luncheon Session/Keynote
|
|
 |
Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
|
| |
|
CER: Informing Public and Private Payer Decision-Making
Once the methods of conducting CER are recognized, how can we enhance the interpretation and real-world application of credible evidence to reduce uncertainty in care decisions? Would the development of an all-payor claims database provide data needed for CER? Public and private sector payers and employers provide their perspectives.
|
|
|
|
 |
Helen Darling, President, National Business Group on Health |
|
 |
Charles Yarborough, MD, MPH, Lead Medical Director and Director of Medical Strategies, Health & Wellness, Lockheed Martin Corporation |
|
 |
Douglas R. Hadley, MD, MBA, Medical Officer, Director Coverage Policy Unit, CIGNA HealthCare
|
|
 |
Brian Sweet, BS Pharm, MBA, Chief Pharmacy Officer, WellPoint, Inc.
|
| |
|
Moderator: Carmella Bocchino, RN, MBA, Executive Vice President, America’s Health Insurance Plans
|
Utilizing CER at the Point of Care to Improve Patient Outcomes
This session will examine physicians’ perspectives for using CE data for treating individual patients at the point of care, and will explore the opportunities and challenges of translating population-based findings into individualized treatment plans. It will address the use of health information technology and decision support tools to make CER results available in the physician office or at the hospital bedside, and examine how patients and other consumer groups may (mis)use CER information.
|
|
|
|
 |
Walter "Buzz" Stewart, PhD, MPH, Associate Chief Research Officer, Center for Health Research & Rural Advocacy Geisinger Health System
|
|
 |
Scott S. Young, MD, Senior Medical Director and Co-Executive Director, Care Management Institute, Kaiser Permanente
|
|
 |
Steven D. Pearson, MD, MSc, FRCP, President, Institute for Clinical and Economic Review (ICER) and Visiting Scientist, Department of Bioethics, National Institutes of Health
|
|
 |
Myrl Weinberg, CAE, President, National Health Council
|
|
 |
Moderator: Robert Mechanic, MBA, Executive Director, Health Industry Forum, Heller School for Social Policy and Management, Brandeis University
|
|
|
|
|